Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05574140

BreathinG-induced Myocardial and Cerebral Perfusion in Anxiety Disorders

BreathinG-induced Myocardial and Cerebral Perfusion in Anxiety Disorders (B-GLAD)

Status
Recruiting
Phase
Study type
Observational
Enrollment
84 (estimated)
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This study aims to view variations in MRI measurements of the heart and the brain in people with anxiety versus healthy volunteers. The MRI measurements used will be Oxygenation-Sensitive Cardiac MRI (OS-CMR), a recent type of MRI which is safe, fast, and non-invasive.

Detailed description

The investigators will prospectively analyze OS-CMR data from patients with a generalized anxiety disorder from one site. The investigators will observe how an anxiety disorder affects the OS-CMR data. In a follow-up MRI scan, the investigators will look at the OS-CMR of a subgroup who have anxiety disorder and are also undertaking cognitive behavioural therapy to asses how and if this therapy affects the OS-CMR data.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCardiac MRIThe 4-minute breathing maneuver comprised of 2 minutes of normal breathing and 1-min hyperventilation (rate of 30 breaths per minute) followed by a maximal breath-hold. This technique is used in Oxygenation Sensitive CMR, a type of MRI, and will induce a vasoactive response visible in cardiac and cerebral MRI images

Timeline

Start date
2022-07-15
Primary completion
2025-03-15
Completion
2025-09-15
First posted
2022-10-10
Last updated
2024-10-24

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05574140. Inclusion in this directory is not an endorsement.